Dexamethasone in the treatment of the alcohol withdrawal syndrome

Bryon Adinoff, Birgit Pols

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pre-clinical studies and clinical case reports suggest that glucocorticoids may be efficacious in ameliorating the signs and symptoms of the alcohol withdrawal syndrome. In order to evaluate the efficacy of the glucocorticoid dexamethasone upon alcohol withdrawal, we administered 4 mg of dexamethasone intravenously to eight alcohol dependent men during withdrawal. Withdrawal severity, as determined by the amount of lorazepam required to ameliorate withdrawal symptoms, was compared to eight other withdrawing patients not administered dexamethasone. There was no significant difference between the two groups in the amount of lorazepam required to treat to withdrawal symptoms. This preliminary study suggests that dexamethasone, in doses expected to suppress hypothalmic-pituitary-adrenal axis activation, is not efficacious in the treatment of alcohol withdrawal.

Original languageEnglish (US)
Pages (from-to)615-622
Number of pages8
JournalAmerican Journal of Drug and Alcohol Abuse
Volume23
Issue number4
StatePublished - 1997

Fingerprint

Dexamethasone
Alcohols
Lorazepam
Substance Withdrawal Syndrome
Glucocorticoids
Therapeutics
Signs and Symptoms

Keywords

  • Alcohol Withdrawal
  • Alcoholism
  • Dexamethasone
  • Glucocorticoids

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Clinical Psychology

Cite this

Dexamethasone in the treatment of the alcohol withdrawal syndrome. / Adinoff, Bryon; Pols, Birgit.

In: American Journal of Drug and Alcohol Abuse, Vol. 23, No. 4, 1997, p. 615-622.

Research output: Contribution to journalArticle

Adinoff, Bryon ; Pols, Birgit. / Dexamethasone in the treatment of the alcohol withdrawal syndrome. In: American Journal of Drug and Alcohol Abuse. 1997 ; Vol. 23, No. 4. pp. 615-622.
@article{93496454127241e3a4c3cc23a5098d89,
title = "Dexamethasone in the treatment of the alcohol withdrawal syndrome",
abstract = "Pre-clinical studies and clinical case reports suggest that glucocorticoids may be efficacious in ameliorating the signs and symptoms of the alcohol withdrawal syndrome. In order to evaluate the efficacy of the glucocorticoid dexamethasone upon alcohol withdrawal, we administered 4 mg of dexamethasone intravenously to eight alcohol dependent men during withdrawal. Withdrawal severity, as determined by the amount of lorazepam required to ameliorate withdrawal symptoms, was compared to eight other withdrawing patients not administered dexamethasone. There was no significant difference between the two groups in the amount of lorazepam required to treat to withdrawal symptoms. This preliminary study suggests that dexamethasone, in doses expected to suppress hypothalmic-pituitary-adrenal axis activation, is not efficacious in the treatment of alcohol withdrawal.",
keywords = "Alcohol Withdrawal, Alcoholism, Dexamethasone, Glucocorticoids",
author = "Bryon Adinoff and Birgit Pols",
year = "1997",
language = "English (US)",
volume = "23",
pages = "615--622",
journal = "American Journal of Drug and Alcohol Abuse",
issn = "0095-2990",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Dexamethasone in the treatment of the alcohol withdrawal syndrome

AU - Adinoff, Bryon

AU - Pols, Birgit

PY - 1997

Y1 - 1997

N2 - Pre-clinical studies and clinical case reports suggest that glucocorticoids may be efficacious in ameliorating the signs and symptoms of the alcohol withdrawal syndrome. In order to evaluate the efficacy of the glucocorticoid dexamethasone upon alcohol withdrawal, we administered 4 mg of dexamethasone intravenously to eight alcohol dependent men during withdrawal. Withdrawal severity, as determined by the amount of lorazepam required to ameliorate withdrawal symptoms, was compared to eight other withdrawing patients not administered dexamethasone. There was no significant difference between the two groups in the amount of lorazepam required to treat to withdrawal symptoms. This preliminary study suggests that dexamethasone, in doses expected to suppress hypothalmic-pituitary-adrenal axis activation, is not efficacious in the treatment of alcohol withdrawal.

AB - Pre-clinical studies and clinical case reports suggest that glucocorticoids may be efficacious in ameliorating the signs and symptoms of the alcohol withdrawal syndrome. In order to evaluate the efficacy of the glucocorticoid dexamethasone upon alcohol withdrawal, we administered 4 mg of dexamethasone intravenously to eight alcohol dependent men during withdrawal. Withdrawal severity, as determined by the amount of lorazepam required to ameliorate withdrawal symptoms, was compared to eight other withdrawing patients not administered dexamethasone. There was no significant difference between the two groups in the amount of lorazepam required to treat to withdrawal symptoms. This preliminary study suggests that dexamethasone, in doses expected to suppress hypothalmic-pituitary-adrenal axis activation, is not efficacious in the treatment of alcohol withdrawal.

KW - Alcohol Withdrawal

KW - Alcoholism

KW - Dexamethasone

KW - Glucocorticoids

UR - http://www.scopus.com/inward/record.url?scp=0030708770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030708770&partnerID=8YFLogxK

M3 - Article

C2 - 9366977

AN - SCOPUS:0030708770

VL - 23

SP - 615

EP - 622

JO - American Journal of Drug and Alcohol Abuse

JF - American Journal of Drug and Alcohol Abuse

SN - 0095-2990

IS - 4

ER -